Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa
Authors
Keywords
Diabetes, Obesity, COVID-19, Pandemic, Management, Consensus
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 172, Issue -, Pages 108617
Publisher
Elsevier BV
Online
2020-12-11
DOI
10.1016/j.diabres.2020.108617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
- (2020) Antonio Ceriello et al. DIABETES CARE
- The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease 2019: a Single‐center, Retrospective, Observational Study in Wuhan
- (2020) Yang Zhang et al. DIABETES OBESITY & METABOLISM
- Why is hyperglycemia worsening COVID ‐19 and its prognosis?
- (2020) Antonio Ceriello et al. DIABETES OBESITY & METABOLISM
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risks and benefits at the time of COVID ‐19 pandemic
- (2020) Marco Infante et al. Journal of Diabetes
- Prevalence and impact of diabetes among people infected with SARS-CoV-2
- (2020) G. P. Fadini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- COVID-19 and diabetes from IDF MENA region
- (2020) Jamal Belkhadir DIABETES RESEARCH AND CLINICAL PRACTICE
- Hyperglycaemia on admission to hospital and COVID-19
- (2020) Celestino Sardu et al. DIABETOLOGIA
- DIABETES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM: IMPLICATIONS FOR COVID-19 PATIENTS WITH DIABETES TREATMENT MANAGEMENT
- (2020) DOINA CATRINOIU FARMACIA
- Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights
- (2020) Anca Pantea Stoian et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- COVID‐19: A Lever for the Recognition of Obesity as a Disease? The French Experience
- (2020) Karine Clément et al. Obesity
- The Enigma of Endothelium in COVID-19
- (2020) Savneet Kaur et al. Frontiers in Physiology
- Vitamin D for COVID-19: a case to answer?
- (2020) Adrian R Martineau et al. Lancet Diabetes & Endocrinology
- COVID-19 in people living with diabetes: An international consensus
- (2020) A.E. Caballero et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
- (2020) Alexandros Sachinidis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The epidemiology of obesity
- (2018) Yu Chung Chooi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
- (2012) R. E. Ratner et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More